Phase 3 Schizophrenia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are between 55 and 90 years of age at the time of the initial screening visit.
• People who have been diagnosed with Alzheimer's disease based on the 2024 revised diagnostic criteria set by the Alzheimer's Association Workgroup.
• People who have had a brain scan (MRI or CT) within the past 5 years, taken at or after the time their dementia began, to rule out other brain conditions that could explain their symptoms.
• People who have been experiencing psychotic symptoms (such as hallucinations or delusions, meeting specific international criteria) for at least 2 months before the screening visit — agitation may or may not also be present.

Who may not be able to join:

• People whose psychotic symptoms are mainly caused by a condition other than Alzheimer's disease, such as schizophrenia, schizoaffective disorder, delusional disorder, or a mood disorder with psychotic features.
• People who have had a major depressive episode with psychotic features in the 12 months before screening, or who have a history of bipolar disorder, schizophrenia, or schizoaffective disorder.
• People who have certain safety concerns identified through laboratory tests or other health checks (confirm with trial site for specific details).
• Additional inclusion and exclusion criteria apply beyond those listed here (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.